ICRA
-
Private hospital players expected to add over 30,000 beds in the next 4-5 years for ~Rs 32,500 Cr: ICRA
Hospital chains are also looking at inorganic opportunities, which have led to increasing consolidation in the industry in the last…
Read More » -
Indian hospital industry in pink of health: ICRA
The operating profit margin will remain healthy at over 22 per cent in FY2024, supported by operating leverage and continued…
Read More » -
Pharmaceutical industry headwinds in remission: ICRA
US FDA inspections have gained momentum in the recent past and regulatory risks remain a key monitorable ICRA expects the…
Read More » -
Pricing pressures and regulatory overhang affect margins of Indian pharma cos in FY2023: ICRA
Continued pricing pressures in the US and European markets and cost inflation likely to result in 50-100 bps contraction in…
Read More » -
Pricing pressures and regulatory scrutiny persist in US generics pharma industry: ICRA
Off-late, Indian pharma companies have reported sizeable provisioning and settlement pay-outs against some of the ongoing litigations, which have impacted…
Read More » -
Introduction of GST on non-ICU hospital beds to be credit-neutral for hospital sector: ICRA
This is applicable with effect from July 18, 2022 The GST Council in its latest meeting has decided to impose…
Read More » -
Hospital industry revenue growth to moderate in FY2023 given the large base of FY2022: ICRA
Industry capital expenditure cycle has resumed after a hiatus on account of the pandemic The performance of ICRA’s sample set…
Read More » -
Budget Expectations 2022
Experts put forth their views on the upcoming Budget 2022 Saransh Chaudhary, President, Global Critical Care,…
Read More » -
Hospitals expected to report robust revenue and margin growth in FY2022: ICRA
Occupancy is expected to be in the range of 60-62 per cent while ARPOB is expected to expand by least…
Read More » -
Indian pharma sector to witness estimated growth at 9-11%: ICRA
Growth of Indian pharma industry to be driven by domestic and emerging markets in the next few quarters The revenue…
Read More »